Dimensional and Developmental Profiles of Psychosis in Children and Adolescents

Recruiting N/A Interventional Study
Schizophrenia Psychotic Disorders
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
7 – 20
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
200 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Five collaborating sites in France will study the broad spectrum of schizophrenia in children and adolescents. Patients will be studied with diagnostic interviews, developmental histories, dimensional clinical ratings, comprehensive cognitive assessments, neuroimaging and DNA (copy number variant) analyses (in families and patients who agree), and follow-up of course of illness, cognitive status a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for the Patient: 1. Children and young adults ages 7-20 years with age of onset of psychotic disorder between 7-17 years. 2. Hospitalized or seen for out-patient treatment for a psychotic episode, acute or chronic. 3. DSM-V diagnosis of schizophrenia, schizoaffective disorder, sc…
Contacts

Claudine LAURENT-LEVINSON, M.D., Ph.D.

1 42 16 23 44

claudine.laurent@aphp.fr

CONTACT

Anne BISSERY

1 42 16 34 32

anne.bissery@aphp.fr

CONTACT